Clinical Trial Update: Assessing the Variability Over Time of Tobacco Carcinogen Biomarkers in Smokers - 2

View source ↗

Summary

This update summarizes results from a completed clinical trial studying how tobacco carcinogen biomarkers vary over time in smokers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Snippet

Sponsor: National Institute on Drug Abuse (NIDA) | Conditions: Tobacco Use Disorder | Status: COMPLETED